HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identifying genetic variants associated with ritodrine-induced pulmonary edema.

AbstractINTRODUCTION:
Ritodrine is one of the most commonly used tocolytics in preterm labor, acting as a ß2-adrenergic agonist that reduces intracellular calcium levels and prevents myometrial activation. Ritodrine infusion can result in serious maternal complications, and pulmonary edema is a particular concern among these. The cause of pulmonary edema following ritodrine treatment is multifactorial; however, the contributing genetic factors remain poorly understood. This study investigates the genetic variants associated with ritodrine-induced pulmonary edema.
METHODS:
In this case-control study, 16 patients who developed pulmonary edema during ritodrine infusion [case], and 16 pregnant women who were treated with ritodrine and did not develop pulmonary edema [control] were included. The control pregnant women were selected after matching for plurality and gestational age at the time of tocolytic use. Maternal blood was collected during admission for tocolytic treatment, and whole exome sequencing was performed with the stored blood samples.
RESULTS:
Gene-wise variant burden (GVB) analysis resulted in a total of 71 candidate genes by comparing the cumulative effects of multiple coding variants for 19729 protein-coding genes between the patients with pulmonary edema and the matched controls. Subsequent data analysis selected only the statistically significant and deleterious variants compatible with ritodrine-induced pulmonary edema. Two final candidate variants in CPT2 and ADRA1A were confirmed by Sanger sequencing.
CONCLUSIONS:
We identified new potential variants in genes that play a role in cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) regulation, which supports their putative involvement in the predisposition to ritodrine-induced pulmonary edema in pregnant women.
AuthorsSeung Mi Lee, Yoomi Park, Young Ju Kim, Han-Sung Hwang, Heewon Seo, Byung-Joo Min, Kye Hwa Lee, So Yeon Kim, Young Mi Jung, Suehyun Lee, Chan-Wook Park, Ju Han Kim, Joong Shin Park
JournalPloS one (PLoS One) Vol. 15 Issue 11 Pg. e0241215 ( 2020) ISSN: 1932-6203 [Electronic] United States
PMID33166306 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tocolytic Agents
  • Ritodrine
Topics
  • Adult
  • Case-Control Studies
  • Female
  • Genetic Variation (genetics)
  • Humans
  • Myometrium (drug effects)
  • Obstetric Labor, Premature (drug therapy, genetics)
  • Pregnancy
  • Pulmonary Edema (chemically induced, genetics)
  • Ritodrine (adverse effects)
  • Tocolytic Agents (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: